Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs
10.1186/1479-5876-9-47
Saved in:
Main Authors: | Chen, T.S., Arslan, F., Yin, Y., Tan, S.S., Lai, R.C., Choo, A.B.H., Padmanabhan, J., Lee, C.N., de Kleijn, D.P.V., Lim, S.K. |
---|---|
Other Authors: | SURGERY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/108363 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Development of immortalized hepatocyte-like cells from hMSCs
by: Adisak Wongkajornsilp, et al.
Published: (2018) -
Derivation of clinically compliant MSCs from CD105+, CD24-differentiated human ESCs
by: Lian, Q., et al.
Published: (2012) -
Derivation of clinically compliant MSCs from CD105+, CD24-differentiated human ESCs
by: Lian, Q., et al.
Published: (2011) -
Advanced hydrogels as exosome delivery systems for osteogenic differentiation of mscs: Application in bone regeneration
by: Pishavar, Elham, et al.
Published: (2022) -
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
by: Lai, R.C., et al.
Published: (2012)